We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EBIO: Epoch Pharmaceuticals

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JR who wrote (14)6/14/2001 2:47:14 PM
From: tuck  Read Replies (1) of 33
Not exactly a mover of stock price, but nice to know EBIO has quality chemists, a good prize these days.

>>BOTHELL, Wash., June 14 /PRNewswire/ -- Epoch Biosciences, Inc. (Nasdaq: EBIO - news), a leading provider of proprietary chemistries and reagents that enable genomic research, announced that four of its research scientists were selected as honorees of the 2001 American Chemical Society's (ACS) 56th Northwest Regional Industrial Innovation Award for their discovery of a new class of DNA probes for genetic analysis. The four honorees are: Dr. Igor V. Kutyavin, Dr. Sergei Lokhov, Dr. Eugene Lukhtanov and Dr. Michael Reed, according to William G. Gerber, M.D., chief executive officer of Epoch.

The ACS award recognizes individuals in the Northwest whose creative innovations have contributed to the commercial success of their company and the betterment of the community. The Epoch team discovered a class of DNA probes with attached minor groove binder ligands (MGB probes) that improve current methods of genetic analysis.

The award program, to be held at Seattle University tomorrow, will include a symposium where the honorees will make a technical presentation, as well as an awards ceremony and reception.

Gerber commented, ``We are extremely proud that four of our colleagues were selected by the American Chemical Society as recipients of their prestigious award. The scientific research conducted at Epoch is essential to the success of our business. It is exciting that their peers in the scientific community recognize the hard work and innovation of these individuals.''<<


Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext